Omranikhoo Habib, Shabani Saeed, Esfandiari Atefeh, Salari Hedayat, Rezaee Mehdi
Department of Management, Economics and Health policy, School of Health, Bushehr University of Medical Sciences, Bushehr, Iran.
School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Health Econ Rev. 2025 Jun 16;15(1):51. doi: 10.1186/s13561-025-00647-2.
The condition of renal failure is widely regarded as one of the most significant challenges currently facing public health and typically treated through hemodialysis. The objective of this study was to estimate the Economic burden of hemodialysis in Bushehr province and, by extension, Iran.
This was a cross-sectional and partial economic evaluation study conducted to estimate the Economic burden of hemodialysis using the bottom-up approach in Bushehr province and, consequently Iran. Direct medical costs and the number of hemodialysis patients were attained from health information system (HIS). Indirect costs were calculated by including the cost of lost production due to hospitalization, rest at home, absenteeism from work, and also the loss of productivity due to premature death. finally, to reduce the uncertainty around the data, a two-way sensitivity analysis was carried out.
The mean cost of hemodialysis per patient was calculated to be 169,016 $ Purchasing Power Parity (PPP) resulting in a total economic burden of hemodialysis for Bushehr province and Iran in 2022 as 13,849,321 and 977,677,441$ (which is equivalent to 0.3% Iran's GDP) PPP respectively in 2022. The highest proportion of overall costs (52%) was attributable to indirect costs. Premature death accounted for 82.1% of this figure. While, the largest cost component within the direct costs category (57.2%) belonged to the professional and technical tariffs.
Hemodialysis imposes a significant economic burden on Iranian society. In 2022, the annual cost of hemodialysis for Iran was approximately equivalent to 0.3% of the country's GDP. Preventive measures targeting the factors that predispose individuals to hemodialysis need to be seriously considered.
肾衰竭被广泛认为是当前公共卫生面临的最重大挑战之一，通常通过血液透析进行治疗。本研究的目的是估计布什尔省乃至伊朗血液透析的经济负担。
这是一项横断面和部分经济评估研究，采用自下而上的方法估计布什尔省乃至伊朗血液透析的经济负担。直接医疗成本和血液透析患者数量来自卫生信息系统（HIS）。间接成本通过计算因住院、在家休息、旷工导致的生产损失成本以及因过早死亡导致的生产力损失来计算。最后，为降低数据的不确定性，进行了双向敏感性分析。
计算得出每位患者血液透析的平均成本为169,016美元购买力平价（PPP），2022年布什尔省和伊朗血液透析的总经济负担分别为13,849,321美元和977,677,441美元（相当于伊朗2022年GDP的0.3%）PPP。总成本的最高比例（52%）归因于间接成本。过早死亡占该数字的82.1%。而直接成本类别中最大的成本组成部分（57.2%）属于专业和技术收费。
血液透析给伊朗社会带来了巨大的经济负担。2022年，伊朗血液透析的年度成本约相当于该国GDP的0.3%。需要认真考虑针对使个体易患血液透析的因素采取预防措施。
